Help Me Identify Alzheimer's Microcap Winners
Saturday, October 15, 2016 at 9:01AM
Michael Bigger in Prions, alzheimer, biotech, endal, promis neurosciences, proteins

A year ago, I made an investment in a tiny Canadian development stage biotech company: Promis Neurosciences (TSX:PMN). Promis focuses on novel, disease modifying therapies for the treatment of neurodegenerative diseases, particularly Alzheimer's and ALS.

What's fascinating about Promis is the Alzheimer's Mechanism of Action (MOA) they have identified with their computational platform. Here is a 15 minutes video explaining it in very simple terms.


I'm ready to double down and invest more money in small firms that have intellectual properties related to this MOA. If you know such firm, let me know. Cheers!

Michael Bigger. Follow me on Twitter and StockTwits.

Update on Sunday, October 23, 2016 at 4:27PM by Registered CommenterMichael Bigger

Our readers have identified the following candidates addressing the mechanism of action discussed in this video:

Alzinova: Presentation

Proclara Biosciences (private)

Keep them coming!




Article originally appeared on (
See website for complete article licensing information.